Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.25    0.00 (0.00%)
Bid:
5.00
Ask:
5.50
Spread: 0.50 (10.00%)
Market Cap: £4.66m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Trading Update

14 May 2020 09:44

RNS Number : 9046M
Coral Products PLC
14 May 2020
 

14 May 2020

CORAL PRODUCTS PLC

('Coral' or the 'Company' or the 'Group')

 

Trading Update - Year to 30 April 2020

 

The board of Coral Products PLC, a specialist in the design, manufacture and supply of plastic products is pleased to provide the following update to its previous announcement of 24 March 2020.

 

Summary of results

 

The board reports that on sales of circa £22.3m (2019: £24.7m) it expects, a small loss before taxation and intangibles for the full year and a small drop in EBITDA from the previous year as stated in our half-year statement, notwithstanding the negative effects of the ongoing Covid-19 crisis.

 

Operations

 

The unaudited annual results were marginally affected by the Covid-19 pandemic in March 2020 but a significant impact was noted in April 2020 as the following sales analysis shows:

 

April Sales as a % of Pre Covid-19 Average:

 

 

Group

70%

Coral Products (Mouldings) Ltd

90%

Injection and Blow Moulding

Interpack Ltd

60%

Food Packaging

Tatra Rotalac Ltd

60%

Extrusions

Global One Pak Ltd

40%

Nozzles, Sprays and Caps

 

We are planning for a medium-term level return of demand as a group of around 65% of pre Covid-19 levels though the mix may vary.

 

A good example is Global One Pak Ltd, who are reliant on Chinese imports, where management has moved quickly to change product mix and negotiated new supply terms with customers and suppliers resulting in a record order intake during late April 2020 for delivery from August 2020 and well into 2021.

 

As the restrictions on the general populace are eased, we believe there will be improved demand for our food packaging operations.

 

Moulding operations remain somewhat reduced as regards to injection moulding demand but this is being partially offset by an increased demand in blow moulding.

 

Extrusions is more difficult to forecast as this is determined by economic activity generally.

 

With the uncertainty remaining from the current pandemic we feel unable, with any confidence, to offer guidance for financial performance for the new financial year to 30 April 2021. We continue to monitor and update our performance and are encouraged by our Group's resilient performance to date.

 

Covid-19

 

We are grateful for the government support on offer and where appropriate have availed ourselves of the assistance offered by the payroll protection furlough scheme as well as VAT deferral.

 

Where possible we have also encouraged staff, who remain on the payroll to work from home. All staff members and your board have reduced salaries by 20% for April 2020 and May 2020 which may continue subject to review.

 

In addition, we have negotiated capital holidays ranging from 3 to 6 months with the majority of our asset finance and other lenders. We appreciate this support.

 

We have negotiated a three-year CBIL (Coronavirus Business Interruption Loan) for £1 million pounds, with a 7-month capital repayment holiday, at an interest rate of 4.5% over base, 12 months interest free from the Company's existing bank - Barclays. The existing security arrangements with Barclays will continue, no additional security has been provided by the Company.

 

The loan proceeds were received in our account on 13 May 2020.

 

 

We would like to express our thanks to our Barclays bank relationship counterparts whose guidance and assistance were invaluable.

 

Your board had already taken steps to improve the Company's working capital to aid our pre Covid-19 forecast demand by determining to sell and leaseback the freehold Haydock premises. The subsequent crisis and the inability of surveyors and prospective purchasers to inspect has meant the sale is now on hold until the crisis passes. The book value of this property is £2.5 million and carries a bank loan of £1.75 million. The Company expect to realise sale proceeds in excess of the property's book value.

 

Outlook

 

The actions taken by the board, the continuing resilience of our employees and in the absence of any future government mandated shutdown, give us confidence that we have the means to come through this current crisis.

 

The board recognise its responsibility to provide safe and healthy working conditions to all of the Company's stakeholders and will work to ensure such conditions are forefront when we return to more normal working conditions.

 

We will continue to monitor the performance of our Group and the economic circumstances in general as this crisis unfolds. We will provide updates to the market as appropriate.

 

 

 

This announcement contains inside information for the purpose of Article 7 of the EU Regulation 596/2014 and has been arranged for release by Sharon Gramauskas, Finance Director of the Company.

 

 

For further information, please contact:

 

Coral Products plc

Michael (Mick) Wood, Chief Executive Officer

 

 

Tel: 07788 565 154

 

Nominated Adviser & Broker

Cairn Financial Advisers LLP

Liam Murray

Tony Rawlinson

David Lawman (Corporate Broking)

 

Tel: 020 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFFSALESSELI
Date   Source Headline
31st Oct 20183:09 pmRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSDirector/PDMR Shareholding
23rd Oct 20181:33 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Statement
5th Oct 20187:00 amRNSCompliance with bank lending covenants
4th Oct 20187:00 amRNSProduct Development Partnership
1st Oct 20187:00 amRNSCompliance with bank lending covenants
27th Sep 20183:41 pmRNSFinal Results & Notice of AGM
8th Aug 20187:00 amRNSFurther re: Extension of Supply Contract
1st Aug 20187:00 amRNSTrading and Operational Update
14th Jun 20187:00 amRNSExtension of Supply Contract
20th Apr 20182:07 pmRNSHolding(s) in Company
6th Apr 201812:10 pmRNSDirector Dealing
5th Apr 201812:30 pmRNSDirector dealing
5th Apr 201810:13 amRNSHolding(s) in Company
4th Apr 201810:33 amRNSHolding(s) in Company
12th Mar 201812:55 pmRNSDirector/PDMR Shareholding
16th Feb 20187:00 amRNSDirector/PDMR Shareholding
12th Feb 20182:50 pmRNSDirector/PDMR Shareholding
8th Feb 201812:09 pmRNSDirector/PDMR Shareholding
7th Feb 201811:22 amRNSDirector/PDMR Shareholding
2nd Feb 20184:48 pmRNSDirector dealing
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20182:30 pmRNSHalf-year Report
16th Jan 20182:30 pmRNSDirectorate Change
12th Jan 20182:48 pmRNSTrading Update
11th Oct 20171:04 pmRNSResult of AGM
11th Oct 201711:48 amRNSAGM Statement
14th Sep 20177:00 amRNSFinal Results
11th Sep 201711:11 amRNSBusiness and Asset Purchase
8th Jun 20177:00 amRNSTrading Statement
7th Apr 20177:00 amRNSHaydock Production Facility Update
24th Mar 20177:00 amRNSPurchase of Assets
27th Feb 20178:49 amRNSDirectorate Change
30th Jan 201712:28 pmRNSDirector Dealing
27th Jan 201712:38 pmRNSDirectors' Dealing
27th Jan 20177:00 amRNSTrading Update
8th Dec 20167:00 amRNSHalf Yearly Report
28th Sep 201612:36 pmRNSResult of AGM
28th Sep 20167:00 amRNSAGM Statement
13th Sep 201611:49 amRNSGrant of options to a Director and employees
25th Aug 20167:00 amRNSFinal Results
22nd Aug 201611:35 amRNSNotice of Results
8th Jun 20167:00 amRNSDirectorate Change
7th Apr 20162:37 pmRNSDirector's Shareholding
26th Feb 20161:20 pmRNSHolding(s) in Company
22nd Feb 20167:00 amRNSAcquisition and Placing
19th Jan 20163:46 pmRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.